Trump’s use of malaria drug to combat virus spurs India boon

Published
0

President Donald Trump’s declaration that he was taking an antimalarial drug of dubious effectiveness to help fend off the coronavirus will be welcomed in India.

Trump’s previous endorsement of hydroxychloroquine catalysed a tremendous shift in the South Asian country, spurring the world’s largest producer of the drug to make much more of it, prescribe it for front-line health workers treating the virus and deploy it as a diplomatic tool, despite mounting evidence against using the drug for Covid-19.

Trump recently said that he was taking hydroxychloroquine as a measure of protection against the virus. The US Food and Drug Administration, however, has cautioned against using it outside of hospitals because of the risk of serious heart problems.

Read full AP story here.

Opinion

Editorial

After the talks
Updated 05 Oct, 2026

After the talks

The question of where it ends up, though, will cause stress to the federal government.
Child safety online
05 Oct, 2026

Child safety online

PAKISTANI children are spending more of their lives online, but the safeguards around them are not keeping pace. A...
Rising public debt
05 Oct, 2026

Rising public debt

PAKISTAN’S public debt has surged by 76pc to Rs86.7tr in four years, according to a new government report. Though...
Yemen offensive
Updated 04 Oct, 2026

Yemen offensive

The best option, therefore, is for Muslim and Arab states to help restore the Saudi-Houthi ceasefire.
Growth transition
04 Oct, 2026

Growth transition

PRIME Minister Shehbaz Sharif’s recent call to move from stabilisation to growth, job creation and export ...
Protection at risk
04 Oct, 2026

Protection at risk

THE recent warning from UNHCR should alarm donor governments. Nearly 8.3m refugees and other forcibly displaced...